Cargando…

Novel 9-Benzylaminoacridine Derivatives as Dual Inhibitors of Phosphodiesterase 5 and Topoisomerase II for the Treatment of Colon Cancer

It has been shown that phosphodiesterase 5 (PDE5) inhibitors have anticancer effects in a variety of malignancies in both in vivo and in vitro experiments. The role of cGMP elevation in colorectal carcinoma (CRC) has been extensively studied. Additionally, DNA topoisomerase II (Topo II) inhibition i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ammar, Lina, Lin, Hung-Yu, Shih, Shou-Ping, Tsai, Tsen-Ni, Syu, Yu-Ting, Abdel-Halim, Mohammad, Hwang, Tsong-Long, Abadi, Ashraf H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9866191/ https://www.ncbi.nlm.nih.gov/pubmed/36677898 http://dx.doi.org/10.3390/molecules28020840

Ejemplares similares

Advancements in Phosphodiesterase 5 Inhibitors: Unveiling Present and Future Perspectives
por: ElHady, Ahmed K., et al.
Publicado: (2023)

Synthesis, Molecular Modeling, and Biological Evaluation of Novel Tetrahydro-β-Carboline Hydantoin and Tetrahydro-β-Carboline Thiohydantoin Derivatives as Phosphodiesterase 5 Inhibitors
por: Abadi, Ashraf H., et al.
Publicado: (2011)

Novel benzothiazole derivatives as multitargeted-directed ligands for the treatment of Alzheimer’s disease
por: Hafez, Donia E., et al.
Publicado: (2023)

Design, Synthesis, and Biological Evaluation of O-2-Modified Indenoisoquinolines as Dual Topoisomerase I–Tyrosyl-DNA Phosphodiesterase I Inhibitors
por: Lv, Peng-Cheng, et al.
Publicado: (2014)

5-Methoxybenzothiophene-2-Carboxamides as Inhibitors of Clk1/4: Optimization of Selectivity and Cellular Potency
por: ElHady, Ahmed K., et al.
Publicado: (2021)

Tyrosyl-DNA Phosphodiesterase 1 and Topoisomerase I Activities as Predictive Indicators for Glioblastoma Susceptibility to Genotoxic Agents
por: Wang, Wenjie, et al.
Publicado: (2019)

N-terminal domain of tyrosyl-DNA phosphodiesterase I regulates topoisomerase I-induced toxicity in cells
por: Brettrager, Evan J., et al.
Publicado: (2023)

Phosphodiesterase-5 inhibitors for colon cancer chemoprevention
por: Islam, Bianca N., et al.
Publicado: (2018)

Dual Inhibitors Against Topoisomerases and Histone Deacetylases
por: Seo, Young Ho
Publicado: (2015)

Mechanism of 5′ Topoisomerase II DNA adduct repair by mammalian Tyrosyl DNA phosphodiesterase 2 (Tdp2)
por: Schellenberg, Matthew J., et al.
Publicado: (2012)

Development of (4-Phenylamino)quinazoline Alkylthiourea Derivatives as Novel NF-κB Inhibitors
por: Darwish, Sarah S., et al.
Publicado: (2022)

Apremilast ameliorates acute respiratory distress syndrome by inhibiting neutrophil-induced oxidative stress
por: Tsai, Yung-Fong, et al.
Publicado: (2023)

Repair of topoisomerase 1–induced DNA damage by tyrosyl-DNA phosphodiesterase 2 (TDP2) is dependent on its magnesium binding
por: Shimizu, Naoto, et al.
Publicado: (2023)

Phosphodiesterase Type 5 (PDE5) Inhibitors Sensitize Topoisomerase II Inhibitors in Killing Prostate Cancer Through PDE5-Independent Impairment of HR and NHEJ DNA Repair Systems
por: Chang, Jo-Fan, et al.
Publicado: (2019)

Tyrosyl-DNA phosphodiesterase 1 (TDP1) and SPRTN protease repair histone 3 and topoisomerase 1 DNA–protein crosslinks in vivo
por: Anticevic, Ivan, et al.
Publicado: (2023)

Targeting of Topoisomerase I for Prognoses and Therapeutics of Camptothecin-Resistant Ovarian Cancer
por: Lee, Yu-Chieh, et al.
Publicado: (2015)

Dual Role of Topoisomerase II in Centromere Resolution and Aurora B Activity
por: Coelho, Paula A, et al.
Publicado: (2008)

Topoisomerase-I PS506 as a Dual Function Cancer Biomarker
por: Zhao, Ming, et al.
Publicado: (2015)

Hybrid topoisomerase I and HDAC inhibitors as dual action anticancer agents
por: Cincinelli, Raffaella, et al.
Publicado: (2018)

Dual Targeting Topoisomerase/G-Quadruplex Agents in Cancer Therapy—An Overview
por: Salerno, Silvia, et al.
Publicado: (2022)

Structure-Based Design of Novel Tetrahydro-Beta-Carboline Derivatives with a Hydrophilic Side Chain as Potential Phosphodiesterase Inhibitors
por: Elhady, Ahmed K., et al.
Publicado: (2015)

TDP2/TTRAP Is the Major 5′-Tyrosyl DNA Phosphodiesterase Activity in Vertebrate Cells and Is Critical for Cellular Resistance to Topoisomerase II-induced DNA Damage
por: Zeng, Zhihong, et al.
Publicado: (2011)

Evodiamine Stabilizes Topoisomerase I-DNA Cleavable Complex to Inhibit Topoisomerase I Activity
por: Chan, Agnes L.-F., et al.
Publicado: (2009)

Phosphodiesterases in non-neoplastic appearing colonic mucosa from patients with colorectal neoplasia
por: Mahmood, Badar, et al.
Publicado: (2016)

A Non-Systemic Phosphodiesterase-5 Inhibitor Suppresses Colon Proliferation in Mice
por: Lee, Avelina, et al.
Publicado: (2023)

Effects of camptothecin derivatives and topoisomerase dual inhibitors on Trypanosoma cruzi growth and ultrastructure
por: Lacombe, Otto Kischlat, et al.
Publicado: (2014)

Antibacterial activity of novel dual bacterial DNA type II topoisomerase inhibitors
por: D’Atanasio, Noemi, et al.
Publicado: (2020)

Resveratrol Modulates the Topoisomerase Inhibitory Potential of Doxorubicin in Human Colon Carcinoma Cells
por: Schroeter, Anika, et al.
Publicado: (2014)

Effect of Roflumilast in airways disorders via dual inhibition of phosphodiesterase and Ca(2+)-channel
por: Imam, Faisal, et al.
Publicado: (2020)

Rv2577 of Mycobacterium tuberculosis Is a Virulence Factor With Dual Phosphatase and Phosphodiesterase Functions
por: Forrellad, Marina Andrea, et al.
Publicado: (2020)

Dual Activation of Phosphodiesterase 3 and 4 Regulates Basal Cardiac Pacemaker Function and Beyond
por: Vinogradova, Tatiana M., et al.
Publicado: (2021)

Immobilizing topoisomerase I on a surface plasmon resonance biosensor chip to screen for inhibitors
por: Tsai, Hsiang-Ping, et al.
Publicado: (2010)

Preclinical antitumour activity of F 11782, a novel dual catalytic inhibitor of topoisomerases
por: Kruczynski, A, et al.
Publicado: (2000)

A Dual Topoisomerase Inhibitor, TAS‐103, Induces Apoptosis in Human Cancer Cells
por: Ohyama, Tomoko, et al.
Publicado: (1999)

Dual effectiveness of Alternaria but not Fusarium mycotoxins against human topoisomerase II and bacterial gyrase
por: Jarolim, Katharina, et al.
Publicado: (2016)

The dual topoisomerase inhibitor A35 preferentially and specially targets topoisomerase 2α by enhancing pre-strand and post-strand cleavage and inhibiting DNA religation
por: Zhao, Wuli, et al.
Publicado: (2015)

Topoisomerase IIα mediates TCF-dependent epithelial–mesenchymal transition in colon cancer
por: Zhou, Q, et al.
Publicado: (2016)

DNA Topoisomerase II Is Involved in Regulation of Cyst Wall Protein Genes and Differentiation in Giardia lamblia
por: Lin, Bo-Chi, et al.
Publicado: (2013)

Expanding the type IIB DNA topoisomerase family: identification of new topoisomerase and topoisomerase-like proteins in mobile genetic elements
por: Takahashi, Diane T, et al.
Publicado: (2019)

The short-term bronchodilator effects of the dual phosphodiesterase 3 and 4 inhibitor RPL554 in COPD
por: Singh, Dave, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_jrii8jf88q27ls0pkn47h7voit